Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$5.32B
sum of reported positions
Reported positions
737
Changes vs prior quarter
737
326 new · 57 exited
Filings on record
8
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q2 2024
Across 192 measured positions in 6 quarters, the typical new or larger position finished −3.0 pts against the S&P 500 and 44% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 214K | $79.8M | 1.5% | |
| 223K | $76.5M | 1.4% | |
| 1.05M | $75.7M | 1.4% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $2.67B | $5.32B |
| Positions | 468 | 737 |
| Biggest line | — | GE Aerospace 2% |
| 324K |
| $72.6M |
| 1.4% |
| 324K | $72.2M | 1.4% |
| 387K | $71.6M | 1.3% |
| 206K | $70.1M | 1.3% |
| 72K | $69.1M | 1.3% |
| 183K | $68.3M | 1.3% |
| 51K | $67.7M | 1.3% |
| 132K | $67.6M | 1.3% |
| 188K | $66.7M | 1.3% |
| 205K | $64.3M | 1.2% |
| 131K | $64.2M | 1.2% |
| 133K | $60.4M | 1.1% |
| 302K | $58.7M | 1.1% |
| 1.3M | $56.3M | 1.1% |
| 219K | $55.8M | 1.1% |
| 1.06M | $52.8M | 1.0% |
| 120K | $51M | 1.0% |
| 288K | $50.8M | 1.0% |
| 187K | $48.6M | 0.9% |
| 385K | $47.1M | 0.9% |
| 1.04M | $46.9M | 0.9% |
| 139K | $45.4M | 0.9% |
Xplr Infrastructure, LP (XIFR)
13K shares
Novocure (NVCR)
10K shares
4d Molecular Therapeutics (FDMT)
11K shares
Geopark (GPRK)
16K shares
Nextdoor Holdings (NXDR)
65K shares
Himalaya Shipping (HSHP)
11K shares
Crescent Energy Company (CRGY)
14K shares
Macrogenics (MGNX)
30K shares
Hafnia (HAFN)
21K shares
Ginkgo Bioworks Holdings (DNA)
13K shares
Zentalis Pharmaceuticals (ZNTL)
26K shares
Annexon (ANNX)
21K shares
Lenz Therapeutics (LENZ)
18K shares
Jumia Technologies (JMIA)
13K shares
Magnachip Semiconductor (MX)
19K shares
C4 Therapeutics (CCCC)
19K shares
Crexendo (CXDO)
11K shares
Luxexperience B.V. (LUXE)
11K shares
Cerus (CERS)
24K shares
Taboola.Com (TBLA)
13K shares
Clear Channel Outdoor Holdings (CCO)
23K shares
Granite Ridge Resources (GRNT)
11K shares
Eledon Pharmaceuticals (ELDN)
11K shares
Spero Therapeutics (SPRO)
16K shares
Fate Therapeutics (FATE)
13K shares
